Impacts of CyhospitalclinE downstream vimentin on proliferation, invasion and apoptosis of hepatoma HepG2 cell

被引:0
|
作者
Hu, Gejile [1 ]
Jia, Fuqun [2 ]
Gao, Naikang [3 ]
Han, Yanqiu [1 ]
机构
[1] Inner Mongolia Med Univ, Affiliated Hosp, Dept Lab Med, 1 Tongdao North Rd, Hohhot 010050, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Affiliated Hosp, Dept Pharm, Hohhot 010050, Inner Mongolia, Peoples R China
[3] Inner Mongolia Med Univ, Affiliated Hosp, Dept Neurosurg, 1 Tongdao North Rd, Hohhot 010050, Inner Mongolia, Peoples R China
关键词
Interference RNA; CyclinE; vimentin; apoptosis; CANCER; MIGRATION; MOTILITY; CLEAVAGE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To build vimentin (VIM) interference RNA eukaryotic expression vector and observe hepatoma HepG2 cell's capacity of proliferation, apoptosis, changes of its capability of invasion and transfer after CyclinE downstream VIM expression is suppressed. Methods: Firstly, CyclinE gene was knocked out by RNA inference; the changes of HepG2 cell's capacity of proliferation and level of VIM mRNA and protein were observed. Secondly, eukaryotic expression vector of CyclinE downstream VIM interference RNA was built. Thirdly, MTT and Transwell small chamber were used to detect the change of cell's capacity of proliferation and invasion after VIM was silent, and flow cytometry in level of apoptosis. Results: Eukaryotic expression vectors of new biological target VIM interference RNA were built, namely PVIM-1, PVIM-2, PVIM-3 and PVIM-4. CyclinE gene knock-out could prominently suppress HepG2 cell proliferation. Level of VIM mRNA and protein expression was down-regulated after CyclinE-1mRNA was down-regulated. After VIM expression was down-regulated, HepG2 cell's capacity of proliferation and invasion were weakened and apoptosis increased. Conclusion: VIM is involved in proliferation, invasion, leading to more severe cell apoptosis.
引用
收藏
页码:5564 / 5571
页数:8
相关论文
共 50 条
  • [1] Inhibitory effect of lingonberry extract on HepG2 cell proliferation, apoptosis, migration, and invasion
    Zhu, Liangyu
    Zhang, Yandong
    Li, Yongchun
    Wang, Hua
    Shen, Guang
    Wang, Zhenyu
    PLOS ONE, 2022, 17 (05):
  • [2] Inhibitory effect of lingonberry extract on HepG2 cell proliferation, apoptosis, migration, and invasion
    Zhu, Liangyu
    Zhang, Yandong
    Li, Yongchun
    Wang, Hua
    Shen, Guang
    Wang, Zhenyu
    PLOS ONE, 2022, 17 (07):
  • [3] Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15
    Xudong Liu
    Jian Liang
    Gang Li
    Molecular Biology Reports, 2010, 37 : 2235 - 2239
  • [4] Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15
    Liu, Xudong
    Liang, Jian
    Li, Gang
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (05) : 2235 - 2239
  • [5] Apoptosis induced by nucleosides in the human hepatoma HepG2
    Suh-Ching Yang
    Che-Lin Chiu
    Chi-Chang Huang
    Jiun-Rong Chen
    World Journal of Gastroenterology, 2005, (40) : 6381 - 6384
  • [6] Apoptosis induced by nucleosides in the human hepatoma HepG2
    Yang, Suh-Ching
    Chiu, Che-Lin
    Huang, Chi-Chang
    Chen, Jiun-Rong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (40) : 6381 - 6384
  • [7] Effects of the downregulation of SnoN expression on HepG2 cell proliferation and apoptosis
    Wang, Wenqi
    Liu, Changhong
    Wang, Yiguo
    Cao, Lili
    MOLECULAR MEDICINE REPORTS, 2013, 7 (04) : 1324 - 1328
  • [8] MIR-21 ON PROLIFERATION IN HEPATOMA HEPG2 CELLS
    Deng, Xuesong
    Cheng, Jun
    Zhan, Naiyang
    Chen, Janwei
    Zhan, Yongqiang
    Ni, Yong
    Liao, CaiXian
    ACTA MEDICA MEDITERRANEA, 2022, 38 (04): : 2517 - 2525
  • [9] Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells
    Chen, Chuan
    Han, Zhu
    Yang, Minjie
    Jiang, Zhongke
    Ou, Xiuyuan
    MEDICINE, 2020, 99 (17) : E19848
  • [10] Effects of HDAC inhibitors on proliferation and differentiation of the human hepatoma cell line HepG2
    Augspurger, C.
    Gross, A.
    Riester, D.
    Wegener, D.
    Schober, A.
    Gottwald, E.
    Weibezahn, K. F.
    CYTOTHERAPY, 2006, 8 : 51 - 51